[1]熊壮,王建华.溶瘤病毒在肝癌介入治疗中的应用[J].介入放射学杂志,2007,(03):206-208.
　XIONG Zhuang,WANG Jian-hua.The value of oncolysis virus in treating liver cancer[J].journal interventional radiology,2007,(03):206-208.
点击复制

溶瘤病毒在肝癌介入治疗中的应用()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2007年03期
页码:
206-208
栏目:
综述
出版日期:
2007-03-15

文章信息/Info

Title:
The value of oncolysis virus in treating liver cancer
作者:
熊壮 ; 王建华
200032  上海  复旦大学附属中山医院放射科
Author(s):
XIONG Zhuang; WANG Jian-hua．
Department of Radiology，Zhongshan Hospital，Fudan University，Shanghai２０００３２，China
关键词:
溶瘤病毒; 肝癌; 介入治疗
分类号:
R７３５.７
文献标志码:
A
摘要:
对于原发性肝癌，传统治疗模式疗效有限，基因治疗代表肿瘤治疗的发展方向。溶瘤病毒是一类具有复制能力的肿瘤杀伤型病毒，依靠病毒本身特异性在肿瘤细胞内的复制杀死并裂解肿瘤细胞。在溶瘤病毒的导入途径上，通常采取瘤内注射、经供血动脉注入的方法，而介入治疗技术正好能满足这一要求。因此，将溶瘤病毒和介入治疗技术有机地结合起来，有望在肝癌的治疗中取得突破。

参考文献/References:

［１］Nettelbeck DM．Virotherapeutics：conditionally replicative adeno-viruses for viral oncolysis［J］．Anticancer Drugs，２００３，１４：５７７-５８４．
［２］Toth K，Tarakanova V，Doronin K，et al．Radiation increases the activity of oncolytic adenovirus cancer gene therapy vectors that overexpress the ADP（E３-１１．６K）protein［J］．Cancer Gene Ther，２００３，１０：１９３-２００．
［３］Cinatl J Jr，Cinatl J，Michaelis M，et al．Potent oncolytic activity of multimutated herpes simplex virus G２０７in combination with vincristine against human rhabdomyosarcoma［J］．Cancer Res，２００３，６３：１５０８-１５１４．
［４］Gomez Manzano C，Yung WK，Alemany R，et a１．Genetically modified adenoviruses against gliomas：from bench to bedside［J］．Neurology，２００４，６３：４１８-４２６．
［５］Heise C，Hermiston T，Johnson L，et a１．An adenovirus E１A mutant that demonstrates potent and selective systemic anti-tumoral efficacy［J］．Nat Med，２０００，６：１１３４-１１３９
［６］de Weese TL，vail der Poel H，Li S，et a１．A phase I trial of CV７０６，a replication competent，PSA selective oncolytic adenovirus，for the treatment of locally recurrent prostate cancer following radiation therapy［J］．Cancer Res，２００１，６１：７４６４-７４７２．
［７］van Beusechem VW，Mastenbroek DC，van den Doel PB，et a１．Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors［J］．Gene Ther，２００３，１０：１９８２-１９９１．
［８］Shinozaki K，Ebert O，Woo SL．Treatment of multi-focal colorectal carcinoma metastatic to the liver of immune-competentand syngeneic rats by hepatic artery infusion of oncolytic vesicular stomatitis virus［J］．International J Cancer，２００５，１１４：６５９-６６４．
［９］Ebert O，Shinozaki K，Huang TG，et al．Oncolytic vesicular stomatitis virus for treatment of orthotopic hepatocellular carcinoma in immune-competent rats［J］．Cancer Res，２００３，６３：３６０５-３６１１．
［１０］Zager JS，Delman KA，Malhotra S，et al．Combination vascular delivery of herpes simplex oncolytic viruses and amplicon mediated cytokine gene transfer is effective therapy for experimental liver cancer［J］．Molecular Medicine，２００１，７：５６１-５６８．
［１１］Li G，Sham J，Yang J，et al．Potent antitumor efficacy of an E１B５５kDa-deficient adenovirus carrying murine endostatin in hepatocellular carcinoma［J］．International J Cancer，２００５，１１３：６４０-６４８．

相似文献/References:

[1]曹海利,孟巍,白彬.肝癌基因治疗研究新进展[J].介入放射学杂志,2008,(05):375.
　CAO Haili,MENG Wei,BAI Bin.New progress in research of gene therapy for hepatocellular carcinoma[J].journal interventional radiology,2008,(03):375.
[2]陆骊工,胡宝山,李勇,等.中晚期原发性肝癌合并症的介入治疗研究[J].介入放射学杂志,2008,(07):514.
　LU Ligong,HU Baoshan,LI Yong,et al.Study of interventional therapy for complications in advanced primary hepatocellular carcinoma[J].journal interventional radiology,2008,(03):514.
[3]杨伟洪,刘鹏程,梁珊瑚,等.多层螺旋CT血管造影在判断肝癌寄生供血中的价值[J].介入放射学杂志,2008,(09):654.
　YANG Weihong,LIU Pengchen g,LIANG Shanhu,et al.Evaluation of MSCTA for parasitic blood supply in hepatic carcinoma[J].journal interventional radiology,2008,(03):654.
[4]张茵,周兵,许秀芳,等.肝动脉化疗栓塞治疗原发性肝癌存活２０年一例[J].介入放射学杂志,2008,(09):684.
　ZHANG Yin,ZHOU Bing,XU Xiufang,et al.Survival more than２０years after transarterial chemical embolization for hepatocellular carcinoma：A case report[J].journal interventional radiology,2008,(03):684.
[5]官泳松,贺庆.肝癌介入治疗中应用p５３的几个要点[J].介入放射学杂志,2008,(11):761.
　GUAN Yongsong,HE Qing.Essentials in clinical application of p５３for tumors intervention－example of liver cancer[J].journal interventional radiology,2008,(03):761.
[6]肖运平,肖恩华.介入治疗在防治肝癌术后复发中的作用及进展[J].介入放射学杂志,2008,(11):831.
　XIAO Yunping,XIAO Enhua.The role and progress of interventional therapy in the prevention and treatment of postoperative hepatocellular carcinoma recurrence[J].journal interventional radiology,2008,(03):831.
[7]史震山,陈自谦,杨熙章,等.原发性大肝癌患者TACE后S－腺苷蛋氨酸的护肝作用[J].介入放射学杂志,2008,(11):790.
　SHI Zhenshan,CHEN Ziqian,YANG Xizhang,et al.The clinical study on the liver－protection of S－adenosy－methionine in large hepatocellular carcinoma patients after TACE[J].journal interventional radiology,2008,(03):790.
[8]王耀普,杨康健,赵思源,等.兔肝癌模型的改良接种及其DSA影像分析[J].介入放射学杂志,2010,(03):214.
　WANG Yaopu,YANG Kangjian,ZHAO Siyuan,et al.The modified inoculation method for the preparation of rabbit VX２hepatic carcinoma model and DSA imagining observation[J].journal interventional radiology,2010,(03):214.
[9]贺洪德,贺晶,罗中华,等.肝动脉化疗栓塞联合门静脉栓塞治疗中晚期肝癌的疗效评价[J].介入放射学杂志,2010,(03):191.
　HE Hongde,HE Jing,LUO Zhonghua,et al.Evaluation of the therapeutic effect of hepatic arterial chemoembolization combined with portal chemoembolization for advanced hepatic carcinomas[J].journal interventional radiology,2010,(03):191.
[10]李广琪,曹玮,李超,等.肝动脉热灌注对兔肝VX２肿瘤及正常肝组织血管渗透性功能的作用[J].介入放射学杂志,2010,(03):217.
　LI Guangqi,CAO Wei,LI Chao,et al.Influence of hepatic artery thermotherapy on the vascular permeability of hepatic tumor tissue and normal liver tissue in VX２tumor－bearing rabbits[J].journal interventional radiology,2010,(03):217.

备注/Memo

备注/Memo:
收稿日期：２００６-１２-１８
更新日期/Last Update: 2007-03-15